DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-111421			PS-SP PhaseIII Clinical Study; Investigation to find new formulation of mesalazine for treatment of patients with active Ulcerative Colitis.	PS-SP PhaseIII Clinical Study; Investigation to find new formulation of mesalazine for treatment of patients with active Ulcerative Colitis.	Ulcerative Colitis	Intervention name : PS-SP Dosage And administration of the intervention : PS-SP suppository 1g or placebo is administered rectally once a day. Control intervention name : null	Kyorin Pharmaceutical Co.,LTD	NULL		15	74	BOTH		Phase 3	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

JPRN-JapicCTI-111421

PS-SP PhaseIII Clinical Study; Investigation to find new formulation of mesalazine for treatment of patients with active Ulcerative Colitis.

Ulcerative Colitis

Intervention name : PS-SP
Dosage And administration of the intervention : PS-SP suppository 1g or placebo is administered rectally once a day.
Control intervention name : null

Kyorin Pharmaceutical Co.,LTD

NULL

BOTH

Phase 3

NULL